drug access

Views & Analysis

Ensuring access: how to help patients seeking experimental t...

The impact of the debate on the Right-to-Try laws in the US and what needs to be done to improve access to innovative drugs.

Views & Analysis

Going beyond CSR to reach ‘the two billion’

Impact of putting access to medicine at the core of pharma businesses.

News

NHS "isn't delivering equitable care for rare diseases"

A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

Sales & Marketing

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

Editor's Picks